Antibody against human cardiac troponin I and use thereof
AssigneeGuagndong Feipeng Biological Co., Ltd.
InventorsPeng CUI, Zhiqiang HE, Yuan MENG
Life of this patent
Estimating the term…
Abstract
Disclosed is an isolated binding protein including a cardiac troponin I (cTnI) antigen binding domain, and preparation and a use and the like of the binding protein. The antigen binding domain includes at least one complementarity determining region selected from an amino acid sequence defined in this article, or has at least 80% sequence identity with the complementarity determining region of the amino acid sequence and has KD≤7.51×10−8 mol/L affinity with cTnI. The binding protein may be used in the detection field of the cTnI.
Claims25
An isolated binding protein comprising an antigen binding domain, wherein the antigen binding domain comprises at least one complementarity determining region selected from the following amino acid sequences, or has at least 80% sequence identity with the complementarity determining region of the following amino acid sequences and has KD≤9.96×10−8 mol/L affinity with a cTnI;
- a complementarity determining region CDR-VH1 is G-Y-X1-F-T-X2-Y-V-X3-H, wherein,
- the X1 is S or T, X2 is I or L, and the X3 is V, L or I;
- a complementarity determining region CDR-VH2 is Y-I-X1-P-Y-X2-D-G-T-X3-Y-N-E-K, wherein,
- the X1 is Q, N or Y, the X2 is I or L, and the X3 is R or K;
- a complementarity determining region CDR-VH3 is R-X1-G-Y-G-X2-Y-G-L-A, wherein
- the X1 is S or T, and the X2 is Q, N or G;
- a complementarity determining region CDR-VL1 is S-X1-G-A-X2-T-T-S-X3-Y-A-N, wherein,
- the X1 is S or T, the X2 is A or V, and the X3 is Q or N;
- a complementarity determining region CDR-VL2 is G-S-X1-N-R-X2-P, wherein,
- the X1 is N or Q, and the X2 is A or V;
- a complementarity determining region CDR-VL3 is A-X1-V-Y-S-N-X2-W, wherein,
- the X1 is I or L, and the X2 is Q, H or N.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.